PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Pathogen-directed trials are among the most important trials that clinicians need to guide therapy but are also incredibly difficult to design and enroll. Rachel Britt (@RachelBPharmD) gets a behind-the-scenes interview with Adam Stewart (@adm_stewart), lead investigator of MERINO-2, and Jason Pogue (@jpogue1), lead investigator of OVERCOME. They discuss original intentions and evolving expectations to investigate optimal antibiotic therapy for multidrug resistant bacteria. Listen in for the insider analysis!
Jason Pogue, PharmD, BCPS, BCIDP
Jason Pogue is a Clinical Professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and Infectious Diseases. He completed a PGY-1 pharmacy residency at the University of Pittsburgh Medical Center followed by an infectious diseases PGY-2 residency at the University of Michigan Health Systems. His research interests focus on epidemiology and management of multi-drug resistant Gram-negative organisms and antimicrobial stewardship.
Adam Stewart, MBBS, MPH
Dr Adam Stewart is a Transplant Infectious Disease Fellow at Massachusetts General Hospital. He is an Australian-trained Infectious Diseases Physician and Clinical Microbiologist. He is the Editorial Fellow for the American Journal of Transplantation. He is an active and productive Physician-Scientist with more than 80 publications and has received numerous research awards and grants.
